Current treatment and patient education strategies are discussed by Jerry Meece, RPh, CDCES, FACA, FADCES, and Jennifer D. Goldman, RPh, PharmD, CDCES, BC-ADM, FCCP.
EP. 1: The Increasing Prevalence of Diabetes
Jerry Meece, RPh, CDCES, FACA, FADCES, initiates a discussion around the increasing prevalence of patients diagnosed with diabetes.
EP. 2: Treatment Adherence Strategies for Patients with Diabetes
Jennifer D. Goldman, RPh, PharmD, CDCES, BC-ADM, FCCP, explores strategies to increase patient adherence to treatment.
EP. 3: Patient Assistance Programs in Patients with Diabetes
Pharmacy experts share insights on the impact of assistance programs offered for patients with diabetes.
EP. 4: Individualizing Care for Patients With Diabetes
Drs Jerry Meece and Jennifer Goldman offer treatment plans based on individualized patient care models for patients with diabetes.
EP. 5: Strategies to Educate Patients with Diabetes
Key opinion leaders share strategies to effectively educate patients on diabetes.
EP. 6: Selecting Appropriate Drug Therapies for Diabetes
Drs Goldman and Meece explore an array of drug therapies available to treat diabetes.
EP. 7: Educating on Proper Insulin Administration Techniques
Drs Goldman and Meece discuss factors surrounding insulin administration.
EP. 8: Barriers to Optimal Treatment for Patients With Diabetes
Dr Meece navigates insulin therapy education and ensuring patient adherence.
EP. 9: Ensuring Proper Injection Technique and Handling
Jennifer D. Goldman, RPh, PharmD, CDCES, BC-ADM, FCCP, discusses topics to address with patients to ensure appropriate self-administration of insulin.
EP. 10: Optimizing Usage of Insulin Pens and Strategies to Educate Patients
Experts provide suggestions for optimizing patient education by encouraging patient engagement.
EP. 11: Overcoming Fears of Injections
Addressing fears surrounding insulin injections through education may positively impact treatment adherence.
EP. 12: Pharmacists are a Resource for Patients
Drs Meece and Goldman share final thoughts on the overall current and future treatment landscape for diabetes.